Comparison of Outreach Approaches to Increase Enrollment in a Healthy Cholesterol Study
NCT ID: NCT02086539
Last Updated: 2017-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2014-04-30
2016-07-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Adherence to Statins Among Minority Populations
NCT02037685
Default Bulk Ordering and Text Messaging to Enhance Outreach for Lipid Screening (Missing Lipids)
NCT05724615
Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
NCT01227330
Intervention to Educate and Improve Underrepresented Populations' Participation in Clinical Trials
NCT04863092
Promoting Cholesterol Screening
NCT01930149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Letter
This arm will receive the recruitment letter in a business sized envelope. The letter states the participant will receive a $25 check upon enrollment into the study.
No interventions assigned to this group
Large Envelope
This arm will receive the recruitment letter in an 8.5 x 11 inch envelope. The letter states the participant will receive a $25 check upon enrollment into the study.
Large Envelope
Priority Mail
Group 3 will receive a recruitment letter shipped via USPS priority mail. The letter states the participant will receive a $25 check upon enrollment into the study.
Priority Mail
Amazon
This arm will receive a recruitment letter with the image of an Amazon gift card and told they will receive the $25 gift card if they enroll in the study.
Amazon
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Large Envelope
Priority Mail
Amazon
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* LDL \> or = 130 mg/dl - measured during screening
* A prescription filled for statin medication within the last 12 months
* Medication Possession Ratio (MPR) \<80%
* CVS Caremark Beneficiary
Exclusion Criteria
* Contraindication to further statin use or have suffered side effects from statins, such as myopathy
* Will not or cannot give consent
* History of active or progressive liver disease or abnormal liver function tests on baseline screening
* Currently participating in another clinical trial with related aims
* Co-morbidities likely to lead to death within a short-period
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rutgers University
OTHER
National Institute on Aging (NIA)
NIH
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kevin G Volpp, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
816003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.